Search

everythinglearnresearchcommunity

for

Search:↓

The reconstructed skin model from hair follicles functions like human skin in processing chemicals and can be used to test ingredient safety.

Glycyrrhizic acid and licorice extract can significantly reduce unwanted hair growth.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

New effective scar treatments are urgently needed due to the current options' limited success.

Skin development in mammals is controlled by key proteins and signals from underlying cells, involving stem cells for maintenance and repair.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Targeting specific cell interactions may help treat skin fibrosis.

The 2004 hair research meeting presented new findings on hair cell differentiation, genetic factors in hair loss, hair pigmentation, and potential targeted therapies.

Artificial skin development has challenges, but new materials and understanding cell behavior could improve tissue repair. Also, certain growth factors and hydrogel technology show promise for advanced skin replacement therapies.

Thyroid hormones help hair grow, reduce hair loss, and increase hair pigment.

Growth factors are crucial for hair development and could help treat hair diseases.

Nanoparticles can effectively treat diseases by modifying blood vessel growth.

Retinoic acid can change skin structures in vertebrates, like turning scales into feathers or hair buds into glands.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

CO2 laser treatment for aging skin significantly changes immune system-related genes.

Let-7b helps alpaca hair grow by reducing TGFβR I protein.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

Restoring hair follicle immune privilege may help treat alopecia areata.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Researchers found four distinct fibroblast types in human skin, which could help in treating wounds and fibrotic diseases.

NK cells play a role in skin diseases like eczema and psoriasis.

Certain cytokines and growth factors can inhibit hair growth and may affect alopecia areata.

17β-estradiol can reduce inflammation in the skin.

More research is needed to understand and treat morphea effectively.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Trichloroethylene causes skin inflammation in mice by increasing certain immune proteins.

The DPCP/HPβCD complex improves solubility and anti-inflammatory effects for alopecia areata treatment.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

Certain cytokines may cause or be affected by immune skin diseases, suggesting possible new treatments.